WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Judy Pan
Patent Agent
Patents and Innovations
Palo Alto
jpan@wsgr.com

D650-223-1632

Download vCard
Open PDF

Dr. Judy Pan is a patent agent in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations practice. Judy’s background is in small molecule chemistry, organic chemistry, and supramolecular chemistry. She applies her experience to patent prosecution, freedom-to-operate, and due diligence matters for clients in the life sciences.

Judy earned her Ph.D. in chemistry from UC Berkeley, where she worked in the physical organic chemistry field. Her thesis focused on studying structure-activity relationships in supramolecular catalyst systems.

Experience

Dr. Judy Pan is a patent agent in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations practice. Judy’s background is in small molecule chemistry, organic chemistry, and supramolecular chemistry. She applies her experience to patent prosecution, freedom-to-operate, and due diligence matters for clients in the life sciences.

Judy earned her Ph.D. in chemistry from UC Berkeley, where she worked in the physical organic chemistry field. Her thesis focused on studying structure-activity relationships in supramolecular catalyst systems.

Education
  • Ph.D., Chemistry, University of California, Berkeley

    NSF Graduate Research Fellow

  • B.A., Chemistry, Cornell University

    Magna Cum Laude, ACS Organic Division Undergraduate Award in Organic Chemistry

Admissions
  • U.S. Patent and Trademark Office
Credentials
Education
  • Ph.D., Chemistry, University of California, Berkeley

    NSF Graduate Research Fellow

  • B.A., Chemistry, Cornell University

    Magna Cum Laude, ACS Organic Division Undergraduate Award in Organic Chemistry

Admissions
  • U.S. Patent and Trademark Office

Select Publications

  • Co-author, “Impact of Host Flexibility on Selectivity in an Enantioselective Aza-Darzens Reaction,” 144 Journal of the American Chemical Society, 2022
  • Co-author, “Syntheses of Amorfrutins and Derivatives via Tandem Diels-Alder and Anionic Cascade Approaches,” 86(16) The Journal of Organic Chemistry, 2021
  • Co-author, “An Untargeted Approach for Revealing Electrophilic Metabolites,” 15(11) ACS Chemical Biology, 2020
Insights

Select Publications

  • Co-author, “Impact of Host Flexibility on Selectivity in an Enantioselective Aza-Darzens Reaction,” 144 Journal of the American Chemical Society, 2022
  • Co-author, “Syntheses of Amorfrutins and Derivatives via Tandem Diels-Alder and Anionic Cascade Approaches,” 86(16) The Journal of Organic Chemistry, 2021
  • Co-author, “An Untargeted Approach for Revealing Electrophilic Metabolites,” 15(11) ACS Chemical Biology, 2020

Therapeutics and Drug Discovery

  • Small molecule synthesis
  • Small molecules

Chemistry and Material Science

  • Catalysis
  • Chemical synthesis
  • Chemistry
  • Organic chemistry
  • Polymers
  • Supramolecular chemistry
Technical Fluency

Therapeutics and Drug Discovery

  • Small molecule synthesis
  • Small molecules

Chemistry and Material Science

  • Catalysis
  • Chemical synthesis
  • Chemistry
  • Organic chemistry
  • Polymers
  • Supramolecular chemistry
Focus Areas
  • Patents and Innovations
Recent Insights
Client Highlights
Firm Advises Frazier Life Sciences on Patent Matters Related to AirNexis Therapeutics’ $200 Million Series A Financing
On January 9, 2026, AirNexis Therapeutics, a clinical-stage biotech company developing therapeutics for pulmonary diseases, announced the closing of a $200 million Series A financing round and the in-license of a dual PDE3/4 inhibitor in Phase 2 development for chronic obstructive pulmonary disease (COPD) from Haisco Pharmaceutical Group. The financing was led by founder Frazier Life Sciences, with participation from OrbiMed, Life Sciences at Goldman Sachs Alternatives, SR One, Longitude Capital, and Enavate Sciences, among others.
Learn More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.